Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...

Adding durvalumab and bevacizumab to transarterial chemoembolization improved responses and progression-free survival.

A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...

They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.

The NRG-HN004 trial showed that durvalumab did not improve outcomes vs cetuximab in locoregionally advanced head and neck ...

There is a simple discount patient access scheme for durvalumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

A phase 3 clinical trial has shown that patients were 32 per cent less likely to experience cancer recurrence when treated ...

A 'game-changer' study found advanced bladder cancer patients treated with the drug durvalumab were a third less likely to ...